✦ LIBER ✦

Safety and Tolerability of Dalcetrapib in High-Risk Patients with Type 2 Diabetes and/or Metabolic Syndrome

✍ Scribed by Anne Carol Goldberg; Anton F.H. Stalenhoef; Regina Duttlinger-Maddux; David Kallend

Book ID: 119287724
Publisher: Elsevier
Year: 2009
Tongue: English
Weight: 275 KB
Volume: 3
Category: Article
ISSN: 1933-2874
DOI: 10.1016/j.jacl.2009.04.025

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dalcetrapib in High-Risk Patients with T

Dalcetrapib in High-Risk Patients with Type 2 Diabetes Mellitus and/or Metabolic Syndrome

✍ Michael H. Davidson; Anton F.H. Stalenhoef; Jennifer G. Robinson; Regina Duttlin 📂 Article 📅 2009 🏛 Elsevier 🌐 English ⚖ 37 KB

Efficacy and safety of dalcetrapib in ty

Efficacy and safety of dalcetrapib in type 2 diabetes mellitus and/or metabolic syndrome patients, at high cardiovascular disease risk

✍ A. F. H. Stalenhoef; M. H. Davidson; J. G. Robinson; T. Burgess; R. Duttlinger-M 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 586 KB

Safety and Tolerability of Pioglitazone

Safety and Tolerability of Pioglitazone in High-Risk Patients with Type 2 Diabetes

✍ Professor John Dormandy, Mondira Bhattacharya, Anne-Ruth van Troostenburg de Bru 📂 Article 📅 2009 🏛 Springer International Publishing AG 🌐 English ⚖ 289 KB

126 CARDIOVASCULAR RISK IN PATIENTS WITH

126 CARDIOVASCULAR RISK IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WITH OR WITHOUT METABOLIC SYNDROME

✍ Millan, J.; Calzado, C. Garcia; Recarte, C. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 39 KB

High prevalence of the metabolic syndrom

High prevalence of the metabolic syndrome and association with novel cardiovascular risk factors in patients with type 2 diabetes

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 149 KB

8 hs-PCR and cardiovascular risk in type

8 hs-PCR and cardiovascular risk in type 2 diabetic patients with metabolic syndrome

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 157 KB